Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Anshul Bhalla"'
Autor:
Murat Dogan, Christine Watkins, Holly Ingram, Nicholas Moore, Grace M. Rucker, Elizabeth G. Gower, James D. Eason, Anshul Bhalla, Manish Talwar, Nosratollah Nezakatgoo, Corey Eymard, Ryan Helmick, Jason Vanatta, Amandeep Bajwa, Canan Kuscu, Cem Kuscu
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
IntroductionApolipoprotein-L1 (APOL1) is a primate-specific protein component of high-density lipoprotein (HDL). Two variants of APOL1 (G1 and G2), provide resistance to parasitic infections in African Americans but are also implicated in kidney-rela
Externí odkaz:
https://doaj.org/article/90aa22aae60f4501bd8dd9857dc88b19
Autor:
Ambreen Azhar, Makoto Tsujita, Manish Talwar, Vasanthi Balaraman, Anshul Bhalla, James D. Eason, Simonne S. Nouer, Keiichi Sumida, Adam Remport, Isaac E. Hall, Randi Griffin, George Rofaiel, Miklos Z. Molnar
Publikováno v:
Renal Failure, Vol 44, Iss 1, Pp 831-841 (2022)
Kidney transplants (KT) from hepatitis C (HCV) viremic donors to HCV negative recipients has shown promising renal outcomes, however, high incidence of cytomegalovirus (CMV) viremia were reported. We performed a prospective cohort study of 52 HCV neg
Externí odkaz:
https://doaj.org/article/cdcf3979863f4aa7a21b8c2cbaa2a9c5
Autor:
Jiten P. Kothadia, MD, Anshul Bhalla, MD, Miklos Z. Molnar, MD, PhD, Rahul Mohan, MD, Vasanthi Balaraman, MD, Manish Talwar, MD, Ryan Helmick, MD, Corey Eymard, MD, Ian Clark, MD, Richa Jain, MD, Thomas W. Faust, MD, MBE, Jason M. Vanatta, MD, James D. Eason, MD, Satheesh P. Nair, MD
Publikováno v:
Transplantation Direct, Vol 8, Iss 6, p e1342 (2022)
Background. Long-term liver outcome in hepatitis C virus (HCV)-negative kidney recipients who acquired HCV infection from viremic donors is of intense interest in the transplant community. We evaluated the incidence of fibrosis in liver biopsy specim
Externí odkaz:
https://doaj.org/article/8eb7e105f346446aa61a464ecf9d255a
Publikováno v:
BMC Nephrology, Vol 21, Iss 1, Pp 1-6 (2020)
Abstract Background Atypical hemolytic uremic syndrome (aHUS) can result in severe kidney dysfunction, secondary to thrombotic microangiopathy. Eculizumab has been used to treat this disorder, and has resulted in favourable outcomes in both, native a
Externí odkaz:
https://doaj.org/article/5dafad982dde41cb9f12a05e4318923b
Autor:
Uchenna Agbim, Orsolya Cseprekal, Masahiko Yazawa, Manish Talwar, Vasanthi Balaraman, Anshul Bhalla, Pradeep S. B. Podila, Benedict Maliakkal, Satheesh Nair, James D. Eason, Miklos Z. Molnar
Publikováno v:
Renal Failure, Vol 42, Iss 1, Pp 767-775 (2020)
Background We aimed to assess the probability and factors associated with the presence of hepatitis C virus (HCV) antibody among HCV seronegative kidney transplant recipients receiving HCV-infected (nucleic acid testing positive) donor kidneys. Metho
Externí odkaz:
https://doaj.org/article/ed50f412bcfb4593a387fb25c3f52342
Autor:
Masahiko Yazawa, Tibor Fülöp, Orsolya Cseprekal, Manish Talwar, Vasanthi Balaraman, Anshul Bhalla, Ambreen Azhar, Csaba P. Kovesdy, James D. Eason, Miklos Z. Molnar
Publikováno v:
Renal Failure, Vol 42, Iss 1, Pp 1083-1092 (2020)
Background Deceased-donor kidney transplantation (KT) from hepatitis C (HCV)-infected donors into HCV-uninfected recipients (HCV D+/R−) could become standard care in the near future. However, HCV viral replication by viral transmission might lead t
Externí odkaz:
https://doaj.org/article/edcdb67fa5b34ab0b3abfed2316485b7
Autor:
Yousuf Kyeso, MD, Anshul Bhalla, MD, Alyssa P. Smith, BSc, Yaqi Jia, MPH, Safa Alakhdhair, MS, Stephanie C. Ogir, BA, Mohammad Abuzeineh, MD, Daniel C. Brennan, MD, Sami Alasfar, MD
Publikováno v:
Transplantation Direct, Vol 7, Iss 6, p e703 (2021)
Background. Donor-derived cell-free DNA (dd-cfDNA) has generated interest as a biomarker for kidney injury including transplant (KT) rejection. It is possible that the KT biopsy procedure can cause the release of dd-cfDNA, therefore affecting the rel
Externí odkaz:
https://doaj.org/article/5a69230ac7d142caa74a9819fc322baa
Autor:
Laila Lakhani, MD, Sami Alasfar, MD, Anshul Bhalla, MD, Amtul Aala, MD, Avi Rosenberg, MD, Darin Ostrander, PhD, Megan D. Schollenberger, CRNP, Daniel C. Brennan, MD, Evan J. Lipson, MD
Publikováno v:
Transplantation Direct, Vol 7, Iss 2, p e656 (2021)
Background. Donor-derived cell-free DNA (dd-cfDNA) is a useful biomarker of rejection that originates from allograft cells undergoing injury. Plasma levels
Externí odkaz:
https://doaj.org/article/e02840545ee648d781169d28b71c5848
Autor:
Ambreen Azhar, Anshul Bhalla, Rachel C. Forbes, Beatrice P. Concepcion, Roy D. Bloom, Deirdre Sawinski, Miklos Z Molnar, Jennifer Trofe-Clark, Raymond T. Chung, Peter P. Reese, Vasanthi Balaraman, David Shaffer, Ian A. Strohbehn, Behdad Besharatian, Douglas E. Schaubel, Emily A. Blumberg, Mital Shah, David S. Goldberg, Manish Talwar, Laura A Binari, Nahel Elias, James D. Eason, Vishnu S. Potluri, Meghan E. Sise
Publikováno v:
Am J Transplant
Kidney transplantation (KT) from deceased donors with hepatitis C virus (HCV) into HCV-negative recipients has become more common. However, the risk of complications such as BK polyomavirus (BKPyV) remains unknown. We assembled a retrospective cohort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0b3fe99e014e2e1f6466181df9bfec2
https://doi.org/10.1111/ajt.16834
https://doi.org/10.1111/ajt.16834
Autor:
Miklos Z. Molnar, Anshul Bhalla, Vasanthi Balaraman, Praveen K. Potukuchi, Csaba P. Kovesdy, Manish Talwar, Ambreen Azhar, Makoto Tsujita, James D. Eason, Masahiko Yazawa
Publikováno v:
Transplant International. 33:1732-1744
The kidney donor profile index (KDPI) defines an hepatitis C (HCV) positive donor based on HCV antibody (Ab) and/or nucleic acid amplification test (NAT) positivity, with donors who are not actively infected (Ab+/NAT-) also classified as HCV positive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ccb89928a60c00cbfbc2f44c2a9ba30
https://doi.org/10.1111/tri.13743
https://doi.org/10.1111/tri.13743